Netherlands Cancer Institute
Amsterdam, Netherlands
Olaf van Tellingen (PhD) is working as a group leader at the Netherlands Cancer Institute in Amsterdam, The Netherlands. His main focus is on the development of better pharmacotherapies for the treatment of brain cancer, in particular high-grade gliomas.Emphasis is on the development and use of suitable preclinical in vivo models and the role of the blood brain barrier.
